Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Locations section was significantly updated with a large set of new study sites across multiple countries (US states like Arizona, California, Illinois, etc.; Argentina, Australia, EU regions, and more), with deletions removing prior entries.SummaryDifference3%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and may not be about the study, replacing the previous wording. The revision is updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the funding-status notice from the page, which previously warned that government funding could affect data currency and response times. The core study details, contacts, and locations are unaffected by this deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the study details, eligibility criteria, and locations list remained unchanged.SummaryDifference0.2%

- Check94 days agoChange DetectedCore content updated to include government operating status notice and new version v3.2.0; prior version v3.0.2 removed.SummaryDifference1%

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.